Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningioma × Octreotide × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 5 Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Esophageal Neoplasms 4 Weight Loss 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Malnutrition 2 Intestinal Obstruction 2 Duodenal Neoplasms 2 Diarrhea 2 Colorectal Neoplasms 2 Carcinoid Tumor 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vomiting 1 Vipoma 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Somatostatinoma 1 Serotonin Syndrome 1 Sarcoma 1 Rectal Neoplasms 1 Primary Inoperable Thymoma 1

Interventions

Magnetic Resonance Spectroscopy 11 gallium Ga 68 dotatate 6 Everolimus 6 lutetium Lu 177 dotatate 5 Radiosurgery 5 Proton Therapy 5 pembrolizumab 4 Surveys and Questionnaires 4 Specimen Handling 4 Hydroxyurea 4 abemaciclib 3 Tranexamic Acid 3 Surgical Procedures, Operative 3 Ga(III)-DOTATOC 3 Bevacizumab 3 trametinib 2 arginyllysine 2 Yoga 2 Whole Body Imaging 2 Sunitinib 2 Sodium Chloride 2 Radiotherapy 2 Protons 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Imaging 2 Imatinib Mesylate 2 Gadolinium DTPA 2 Fluorodeoxyglucose F18 2 Filgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02333565 2023-05-25

CEVOREM

Assistance Publique Hopitaux De Marseille

Phase 2 Completed

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡